Comparison of quality of life of patients with local distributed breast cancer forms after chemotherapy in regional and system regimes

Show simple item record

dc.contributor.author Dumanskiy, Yu. en
dc.contributor.author Bondar, O. en
dc.contributor.author Tkachenko, O. en
dc.contributor.author Stoliachuk, E. en
dc.contributor.author Ermakov, V. en
dc.date.accessioned 2019-11-12T12:26:46Z
dc.date.available 2019-11-12T12:26:46Z
dc.date.issued 2018
dc.identifier.citation Comparison of quality of life of patients with local distributed breast cancer forms after chemotherapy in regional and system regimes / Yu. Dumanskiy, O. Bondar, O. Tkachenko and others // Eureka: health sciences. – 2018. – № 3. – P. 12–20. en
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/5904
dc.description.abstract For several decades, breast cancer (BC) undoubtedly ranks frst in the structure of oncopathology and is the most common cause of the loss of working capacity of the female population in most countries. Considering the increasing quality of care for patients with breast cancer, there is the need for standardization and implementation of methods to assess not only quantitative but also qualitative component of a comprehensive opinion on the results of therapy. Therefore, an important indicator to be taken into account is the quality of life (QL) of a patient. Defnition of QL of patients with inoperable forms of locally advanced breast cancer before and after neoadjuvant courses of systemic polychemotherapy (SPCT) and selective intra-arterial polychemotherapy in combination with systemic (SIAPCT). 154 patients with LA BC T4A-DN0-3M0, who received comprehensive treatment on the basis of the Donetsk regional antitumor center and the University clinic of the Odessa National Medical University during the period from 2000 to 2017, who received SPCT or SIAPCT as a neoadjuvant course, were included in the study. According to the quality of life during the treatment period, wavelike dynamics with a clear advantage of selective intra-arterial polychemotherapy over the system was observed. According to the quality of health between groups, the marginal statistically signifcant difference in favour of regional PCTs was formed. In a detailed study of each of the options found stable symptomatic scale dependent components of the integral index of quality of life on the severity and duration of intoxication syndrome. On the basis of the results obtained, the statistical advantage of the RMRM remains with the regional PCT. The QL study is a reliable, informative and economical method for assessing the health status of the patient, both at the group and at the individual level. In cancer studies, the evaluation of QL is an important criterion for assessing the effectiveness of treatment and has a prognostic value. en
dc.language.iso en en
dc.subject locally advanced breast cancer en
dc.subject complex treatment en
dc.subject intra-arterial polychemotherapy en
dc.subject systemic polychemotherapy en
dc.subject quality of life en
dc.title Comparison of quality of life of patients with local distributed breast cancer forms after chemotherapy in regional and system regimes en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account